CIT Incの収益Y / Y
CIT Incの収益Y / Yは何ですか。
CIT Group Incの収益Y / Yは80.26%です。
収益Y / Yの定義は何ですか。
過去3年間の年間収益の伸びは、過去3年間で平均した1年間の収益成長率です。
The yearly revenue growth rate is calculated as the percentage change in revenue over the trailing twelve months. For this specific metric, the calculation takes into account a series of the last eight quarterly revenues. The revenue growth is useful for determining the success of the company expanding its main business. Revenue growth of 5% to 10% is usually considered good for large-cap companies. For other companies, a sales growth of over 10% is more desirable.
NYSEのセクタFinanceにおける収益Y / Yの企業と比べるCIT Inc
CIT Incは何をしますか。
CIT is a leading national bank focused on empowering businesses and personal savers with the financial agility to navigate their goals. CIT Group Inc. (NYSE: CIT) is a financial holding company with over a century of experience and operates a principal bank subsidiary, CIT Bank, N.A. (Member FDIC, Equal Housing Lender). CIT's commercial banking segment includes commercial financing, community association banking, middle market banking, equipment and vendor financing, factoring, railcar financing, treasury and payments services, and capital markets and asset management. CIT's consumer banking segment includes a national direct bank and regional branch network.
CIT Incと類似の収益y / y
- China Resources Medicalの収益Y / Yは79.83%です。
- Kabra Extrusiontechnikの収益Y / Yは79.97%です。
- Agile Therapeutics Incの収益Y / Yは79.99%です。
- MBH PLCの収益Y / Yは80.07%です。
- CITの収益Y / Yは80.14%です。
- Matrix Composites & Engineering Ltdの収益Y / Yは80.17%です。
- CIT Incの収益Y / Yは80.26%です。
- BCI Mineralsの収益Y / Yは80.52%です。
- Sprague Resources LPの収益Y / Yは80.55%です。
- UroGen Pharmaの収益Y / Yは80.61%です。
- Solar Industries Indiaの収益Y / Yは80.88%です。
- CytomX Therapeutics Incの収益Y / Yは80.93%です。
- Capital Product Partners L Pの収益Y / Yは81.04%です。